#rese-cel Tech News.
1 story in the last 7 days
The latest rese-cel news, distilled by AI into sharp ~100-word summaries. ByteBrief tracks rese-cel across dozens of tech sources and brings you only what matters, updated hourly. Tap any story for the full brief, or open the original source.
TechYahoo Financeabout 5 hours ago
Cabaletta Bio Eyes Rese-Cel Launch for Autoimmune DiseasesCabaletta Bio delivered positive clinical data from the first four patients in the lowest dose cohort of PC-free rese-cel, an autologous CAR T therapy for autoimmune diseases. 50% of patients showed drug-free responses for six months. The company signed a long-term commercial supply agreement and plans to advance rese-cel toward BLA submission for a commercial launch.
Summaries by ByteBrief